Ketamine–dexmedetomidine for sedation during colonoscopy

Comparison of ketamine–dexmedetomidine versus propofol for sedation during colonoscopy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161205031252N11

Enrollment

Registered

2019-03-11

Start date

2019-03-21

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Malignant neoplasm of colon. Condition 2: Benign neoplasm of colon. Malignant neoplasm of colon Benign neoplasm of colon, rectum, anus and anal canal

Interventions

Intervention 1: Intervention group 1: propofol, 1 mg/kg, intravenous, once, before colonoscopy. Intervention 2: Intervention group 2: dexmedetomidine 0.3 micrograms\kg and ketamine 0.25 mg\kg, intrave

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 70 years Need to perform colonoscopy

Exclusion criteria

Exclusion criteria: American Society of Anesthesiologists (ASA) Score 3 or more Drug addiction Taking psychiatric medications History of allergy to used drugs

Design outcomes

Primary

Measure	Time frame
Sedation score. Timepoint: Every five minutes during colonoscopy and recovery. Method of measurement: Ramsay sedation scale.;Pain severity. Timepoint: Once in recovery time. Method of measurement: Wong-Baker FACES Pain Rating Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Hormati

Ghoum University of Medical Sciences

hormatia@yahoo.com+98 25 3612 2053

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 14, 2026